Did you know cancer cells sound sick?
In this episode of Bite the Orange, Scott Haiges, CEO at Digital Harmonic, talks about his company's innovative developments in signal processing technologies, focusing on CytoAcoustics, which allows acoustic analytics of cell signals to discern between cancer and healthy cells. Scott discusses some of Digital Harmonic’s plans for scaling and taking it to market, as well as different live cell pathology uses he envisions for this technology.
Tune in to learn about bioacoustics and how they might change healthcare’s future.